NYU Langone Health: Perlmutter Cancer Center Researcher Finds New Drug Is Effective Against Lung Cancers Caused by Common Genetic Error
June 05, 2021
June 05, 2021
NEW YORK, June 5 -- NYU Langone Health, an academic medical center affiliated with New York University, issued the following news release:
A new drug reduced tumor size in patients who have lung cancer with a specific, disease-causing change in the gene KRAS, a study found.
The results of the CODEBREAK 100 phase 2 clinical trial were presented June 4, 2021, at the American Society of Clinical Oncology (ASCO) annual meeting and published simultaneously in the New England . . .
A new drug reduced tumor size in patients who have lung cancer with a specific, disease-causing change in the gene KRAS, a study found.
The results of the CODEBREAK 100 phase 2 clinical trial were presented June 4, 2021, at the American Society of Clinical Oncology (ASCO) annual meeting and published simultaneously in the New England . . .